Cited by 267Diabetes, Cardiovascular Risks, and LipoproteinsHealthcare Systems and Public HealthIndigenous Health and Education

Prevalence of the Metabolic Syndrome Among Omani Adults

Open access
Al-Lawati, Jawad A., Mohammed, Ali J., Al-Hinai, Halima Q., Jousilahti, Pekka·2003·Diabetes Care

Abstract

OBJECTIVE: To estimate the prevalence of the metabolic syndrome by age and sex in the Omani population as defined by the third report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III [ATP III]) of North America. RESEARCH DESIGN AND METHODS: We analyzed data from a cross-sectional survey conducted in 2001 containing a probability random sample of 1,419 Omani adults aged > or =20 years living in the city of Nizwa. The metabolic syndrome, defined by the ATP III, was defined as having three or more of the following abnormalities: waist circumference >102 cm in men and >88 cm in women, serum triglycerides > or =150 mg/dl (1.69 mmol/l), HDL cholesterol <40 mg/dl (1.04 mmol/l) in men and <50 mg/dl (1.29 mmol/l) in women, systolic blood pressure > or =130 mmHg and/or diastolic > or =85 mmHg or on treatment for hypertension, and fasting serum glucose > or =110 mg/dl (6.1 mmol/l) or on treatment for diabetes. RESULTS: The age-adjusted prevalence of the metabolic syndrome was 21.0%. The crude prevalence was slightly lower (17.0%). The age-adjusted prevalence was 19.5% among men and 23.0% among women (P = 0.236). Low HDL cholesterol was the most common component (75.4%) of the metabolic syndrome among the study population followed by abdominal obesity (24.6%). Abdominal obesity was markedly higher in women (44.3%) than in men (4.7%). CONCLUSIONS: The prevalence of the metabolic syndrome in Oman is similar to that in developed countries. Future prevention and control strategies should not overlook the importance of noncommunicable disease risk factors in rapidly developing countries.

Integrity signals

Registry

Crossref · 10.2337/diacare.26.6.1781

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Today, the prevalence of visceral obesity associated with metabolic syndrome is two to ten times higher in women in many countries around the world.

    “Today, the prevalence of visceral obesity associated with metabolic syndrome is two to ten times higher in women in many countries around the world [49–51].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Al-Lawati, J. A., Mohammed, A. J., Al-Hinai, H. Q., & Jousilahti, P.
Affiliations
  • Ministry of Health (OM)
  • University of Helsinki (FI)
Venue
Diabetes Care
Published
2003-06-01
Volume
26
Issue
6
Pages
1781-1785
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2113392345
Cited by
267
References
5
Citations by year
2026: 1 · 2025: 4 · 2024: 6 · 2023: 5 · 2022: 6 · 2021: 1 · 2020: 7 · 2019: 11 · 2018: 10 · 2017: 10 · 2016: 10 · 2015: 16 · 2014: 13 · 2013: 13 · 2012: 18
FWCI
7.55
Type
journal article
Language
en
Open access
Locations
  • Diabetes Care (publishedVersion)
  • PubMed (publishedVersion)
Funders
World Health Organization
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Epidemiology › Healthcare Systems and Public Health
  • Health Sciences › Health Professions › General Health Professions › Indigenous Health and Education
Keywords
metabolic syndrome, prevalence, Omani adults, Nizwa, NCEP ATP III criteria, low HDL cholesterol, abdominal obesity, waist circumference, hypertension, dyslipidemia, fasting blood glucose, sex differences, age differences, non-communicable disease risk factors
MeSH terms
Adult, Aged, Blood Glucose, Cardiovascular Diseases, Cross-Sectional Studies, Female, Humans, Life Style, Lipoproteins, HDL, Male, Oman, Triglycerides, Body Mass Index, Prevalence, Cluster Analysis, Metabolic Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review